Satureja hortensis effect on serum glucose, lipids, inflammatory factor and blood pressure in metabolic syndrome patients
- Conditions
- Metabolic Syndrome.Metabolic disorder, unspecified
- Registration Number
- IRCT2014012616372N1
- Lead Sponsor
- Shiraz University of Medical Sciences, Vice Chancellor for Research Affairs
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Waist circumference men = 102cm or 40in and women = 88cm or 35in, Fasting blood glucose = 110 mg/dl, HDL-cholesterol for men < 40 mg/dl and for women < 50 mg/dl, Triglycerides = 150 mg/dl, Blood pressure = 130/85 mm Hg.
Exclusion criteria: hypothyroidism; alcoholism; smoking; auto immune disease; chronic pancreatitis; liver dysfunction; kidney disorder or nephritic syndrome; simultaneous subscription in other interventional study; any inflammatory disease or incidence of infection at start or during the study period; consumption of other drug such as aspirin, propranolol, NSAIDs, any form of steroids and any kind of blood glucose and lipid lowering agent; angioplasty or heart attack positive history; pregnancy and lactating.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Glucose. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;LDL-cholesterol. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;High sensetive- C Reactive Protein. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Blood Pressure (systolic and diastolic). Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Beurer Upper Arm Digital Blood Pressure Monitor.;HDL-cholesterol. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Triglyceride. Timepoint: Begining of study first day and at the end of study 70th dayBegining and end of study. Method of measurement: Laboratory kit, Pars Azmoon.
- Secondary Outcome Measures
Name Time Method Alanine Aminotransferase. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Aspartate Aminotransferase. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: Laboratory kit, Pars Azmoon.;Complete Blood Count. Timepoint: Begining of study first day and at the end of study 70th day. Method of measurement: CBC counter machine, Sysmex.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.